3M Company vs Health Care Select Sector SPDR Fund — how do they compare? 3M Company trades at $163.5 (market cap $84.36B), while Health Care Select Sector SPDR Fund trades at $168.24 (market cap $43.48B). The key difference: 3M Company is the larger of the two by market cap, and 3M Company pays a 1.91% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold 3M Company for 169 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| MMM | XLV | |
|---|---|---|
Market Cap | $84.36B | $43.48B |
Volume | 2,325,301 | 11,121,431 |
Sector | Industrials | — |
52-Week High | $183.79 | $175.68 |
52-Week Low | $141.10 | $141.95 |
Typical Hold Time | 169 Days | 100 Days |
Enterprise Value | $93.58B | — |
Dividend Yield | 1.91% | — |
Signals from Pluang's Aura AI — not financial advice
3M (MMM) trades at $162.12, down 0.93% on the day, with a bearish technical signal and support near $158. The company reported strong Q2 2026 earnings, beating estimates with 5.4% organic growth and a 24.9% adjusted operating margin. Revenue for 2025 was $24.95B with net income of $3.25B, though margins have compressed from prior years. Analysts are mixed with a consensus price target of $191, representing potential upside, but high debt and weak consumer sales pose challenges.
The outlook for MMM is cautiously optimistic amid a genuine turnaround narrative. Investment opportunities include continued operational execution, shareholder returns via dividends and buybacks, and growth in industrial and electronics segments. Key risks involve persistent consumer segment weakness, litigation overhang from PFAS, and macroeconomic pressures affecting demand. The stock's valuation remains elevated with a P/E of 29.06, requiring sustained earnings growth to justify further gains.
XLV trades at $168.81, up 1.03% today, with a bullish technical signal driven by moving averages. The ETF holds 61 healthcare stocks from the S&P 500, offering broad sector exposure at a low 0.08% expense ratio. Recent news highlights its defensive appeal amid market volatility and potential Fed rate hikes, with articles comparing it favorably to peers like IBB and PJP on cost and diversification.
Outlook is positive given healthcare's defensive growth profile and XLV's cost efficiency, but risks include political uncertainty from midterm elections and sector-specific volatility from drug trial outcomes. Wall Street sentiment is constructive, with the ETF near key resistance at $170.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
3M Company conducts operations in electronics, telecommunications, industrial, consumer and office, health care, safety, and other markets. The Company businesses share technologies, manufacturing operations, marketing channels, and other resources. 3M serves customers worldwide.
Read more on MMM →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →